e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2008 , Vol 16 , Num 2
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Choroidal Neovascularization Related with Basal Laminar Drusen Treated with Pegaptanib (Macugen®)
Murat KARAÇORLU1, Serra Arf KARAÇORLU2, Hakan ÖZDEMİR3, Fevzi ŞENTÜRK3
1İstanbul Retina Enstitüsü Şti., İstanbul, Prof. Dr.
2İstanbul Retina Enstitüsü Şti., İstanbul, Doç. Dr.
3İstanbul Retina Enstitüsü Şti., İstanbul, Uz. Dr.
In this study we describe a case of subfoveal choroidal neovascularization secondary to basal laminar drusen, in which severe visual loss occured after photodynamic therapy session. We changed the type of treatment to pegaptanib injections (Macugen®) for achieving regression of the recurrent neovascularization. During one-year, 8 intravitreal injections of pegaptanib has been performed every 6 weeks, and at the end of the follow-up; stabilization of the lesion was achieved with preservation of the visual acuity at the baseline value. Keywords : Choroidal neovascularization, basal laminar drusen, pegaptanib, Macugen, PDT.
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact